Assenagon Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Assenagon Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.55M	Sell	10,573 -309,427	-97%	-$67.8M	﹤0.01%	809
2026 Q1	$60.5M	Buy	+320,000	New	+$55.9M	0.09%	170
2024 Q3	–	Sell	-17,017	Closed	-$1.82M	–	1413
2024 Q2	$1.82M	Sell	17,017 -1,534	-8%	-$169K	﹤0.01%	938
2024 Q1	$2.23M	Sell	18,551 -98	-0.5%	-$12K	0.01%	855
2023 Q4	$2.29M	Sell	18,649 -194	-1%	-$24.2K	0.01%	869
2023 Q3	$2.44M	Sell	18,843 -432	-2%	-$57.6K	0.01%	790
2023 Q2	$2.39M	Sell	19,275 -9,923	-34%	-$1.34M	0.01%	712
2023 Q1	$4.27M	Buy	29,198 +26,962	+1,206%	+$3.99M	0.02%	612
2022 Q4	$356K	Sell	2,236 -3,737	-63%	-$548K	﹤0.01%	1216
2022 Q3	$796K	Sell	5,973 -40,487	-87%	-$6.16M	﹤0.01%	985
2022 Q2	$7.25M	Buy	46,460 +41,794	+896%	+$6.43M	0.03%	459
2022 Q1	$726K	Sell	4,666 -137,936	-97%	-$20M	﹤0.01%	1134
2021 Q4	$18.2M	Buy	142,602 +139,073	+3,941%	+$18.3M	0.05%	222
2021 Q3	$460K	Sell	3,529 -51,431	-94%	-$7.77M	﹤0.01%	1081
2021 Q2	$9.76M	Buy	54,960 +23,717	+76%	+$4.11M	0.03%	344
2021 Q1	$5.13M	Buy	+31,243	New	+$5.14M	0.02%	500
2020 Q3	–	Sell	-8,962	Closed	-$989K	–	1239
2020 Q2	$989K	Sell	8,962 -19,308	-68%	-$2.14M	0.01%	795
2020 Q1	$2.82M	Sell	28,270 -147,551	-84%	-$19.1M	0.02%	296
2019 Q4	$26.2M	Buy	175,821 +150,122	+584%	+$20.4M	0.17%	99
2019 Q3	$3.29M	Sell	25,699 -150,967	-85%	-$20.2M	0.02%	309
2019 Q2	$25.2M	Buy	176,666 +165,249	+1,447%	+$22.2M	0.19%	88
2019 Q1	$1.63M	Buy	+11,417	New	+$1.49M	0.02%	573
2018 Q1	–	Sell	-4,210	Closed	-$567K	–	642
2017 Q4	$567K	Buy	+4,210	New	+$584K	0.01%	594

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Assenagon Asset Management's JAZZ Position: Q2 2026 in Review

Assenagon Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 97% in Q2 2026, selling an estimated $67.8M and leaving 10,573 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #809.

Assenagon Asset Management first reported a position in JAZZ in Q4 2017 and has held it in 23 quarters since. The position peaked at $60.5M in Q1 2026. 642 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Assenagon Asset Management held 10,573 shares of Jazz Pharmaceuticals worth $2.55M as of Q2 2026.
Assenagon Asset Management sold 309,427 Jazz Pharmaceuticals shares in Q2 2026, an estimated $67.8M.
Jazz Pharmaceuticals made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #809 holding.
Assenagon Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2017 and has held it in 23 quarters since.
Assenagon Asset Management's Jazz Pharmaceuticals position peaked at $60.5M in Q1 2026.
642 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.